Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical chemistry"
DOI: 10.1093/clinchem/hvac225
Abstract: BACKGROUND Elevated BNP and the N-terminal fragment of the proBNP (NT-proBNP) are hallmarks of heart failure (HF). Generally, both biomarkers parallel each other. In patients receiving sacubitril/valsartan, BNP remained stable while NT-proBNP decreased. As BNP… read more here.
Keywords: sacubitril valsartan; probnpir; probnp1; bnp probnp ... See more keywords
Association of natriuretic peptide and adverse outcomes in patients with atrial fibrillation: A meta‐analysis
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.13436
Abstract: Studies on the association of elevated B‐type natriuretic peptide (BNP)/N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) level with adverse clinical outcomes have yielded conflicting results in patients with atrial fibrillation (AF). This meta‐analysis aimed to assess the… read more here.
Keywords: level; association; bnp probnp; natriuretic peptide ... See more keywords
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Review"
DOI: 10.1183/16000617.0009-2020
Abstract: Despite the advent of new therapies and improved outcomes in patients with pulmonary arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis remains unchanged. Strategies to improve outcomes are therefore currently… read more here.
Keywords: point care; arterial hypertension; bnp probnp; pulmonary arterial ... See more keywords
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular Diabetology"
DOI: 10.1186/s12933-017-0507-9
Abstract: AbstractBackgroundUse of dipeptidyl peptidase-4 inhibitors (DPP4-i) for the treatment of type 2 diabetes (T2D) has been associated with a possible increase in the risk for heart failure (HF). B-type natriuretic peptide (BNP), which is both… read more here.
Keywords: trial; treatment; bnp probnp; effect ... See more keywords
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0173086
Abstract: Aim Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin amyloidosis (ATTR) are lacking. Methods and results Patients (n = 1617) with any of the… read more here.
Keywords: troponin; transthyretin amyloidosis; cardiac biomarkers; bnp probnp ... See more keywords
Association of Natriuretic Peptide With Adverse Outcomes and Disease Severity After Intracerebral Hemorrhage: A Systematic Review
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2021.775085
Abstract: Background: Over the past decade, many studies have reported the association of brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) with clinical outcome of intracerebral hemorrhage (ICH). However, a broad consensus has not… read more here.
Keywords: probnp level; bnp probnp; disease severity; association ... See more keywords
BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20081820
Abstract: Currently, brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are widely used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical medicine. They are also used as postmortem biomarkers reflecting cardiac function… read more here.
Keywords: medicine; diagnostic biomarkers; dysfunction clinical; bnp probnp ... See more keywords